Seer Inc (SEER)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.95+0.52%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · SEER
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -42.0% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 26.5% |
Growth built into the price is above our model estimate.
The price assumes 68.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name operates in a high-miss-rate industry and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 398 industry peers · Company calendar date is not available
SEER — earnings miss
Dated 2026-05-13
in this current report on Form 8-K and the related information in the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
Why it matters: These proposals may change Seer's plans and affect stockholder value.
Watch forSeer accepts a proposal from Omid Farokhzad or the Radoff-JEC Group.
Also watch forSeer turned down both proposals. It will remain an independent company.
Why it matters: The Board's choice on the acquisition plan could change stockholder value and market views.
Watch forThe Board accepts the proposal or presents a counter-offer.
Also watch forThe Board strongly rejects the proposal. There will be no further talks.
Why it matters: This partnership could prove Seer's technology. It may also increase future revenue.
Supportive ifLook for publications or results from the partnership.
Worry ifNo updates or results are shared by the end of Q3.
Why it matters: If the healthcare sector's revenue growth speeds up, it could benefit Seer Inc. as well. It shows a healthier market environment.
Supportive ifHealthcare sector revenue growth rises above 10% year over year.
Worry ifHealthcare sector revenue growth remains below 10% year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$106 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $334 loss on $10,000 · 3.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,165 loss on $10,000 · 31.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Meeting this revenue target signals progress toward the full year growth goal of $16M-$18M.
Supportive ifQ2 revenue reported at or above $3.1 million.
Worry ifQ2 revenue reported below $3.1 million.
Why it matters: Missing earnings often means there are bigger problems in the business.
Worry ifThe next earnings report shows a miss on revenue or profit.
Less concerning ifEarnings report meets or beats expectations.
Why it matters: This growth is crucial for Seer to show it can recover from recent revenue declines. Meeting guidance would signal improved business momentum.
Supportive ifQ2 revenue reported between $16 million and $18 million.
Worry ifQ2 revenue falls below $16 million.
Why it matters: Keeping or raising the gross profit margin is important for Seer. It shows they manage costs well.
Supportive ifGross profit margin reported at or above 35%.
Worry ifGross profit margin drops below 35%.